Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM.

Wharton's Jelly MSCs: Potential Weapon to Sharpen for Our Battle against DM. Trends Endocrinol Metab. 2020 Feb 05;: Authors: Kassem DH, Kamal MM Abstract Diabetes mellitus (DM) is a devastating metabolic disease. Stem cell therapy provides great hope to all diabetic patients. Umbilical cord (UC) Wharton's jelly mesenchymal stem cells (WJ-MSCs) specifically provides a potential cell therapy for DM. In this article, we discuss major advantages of WJ-MSCs and challenges facing their clinical utility in DM. PMID: 32035737 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32035737?dopt=Abstract

Source: Trends in Endocrinology and Metabolism: TEM - February 4, 2020 Category: Endocrinology Authors: Kassem DH, Kamal MM Tags: Trends Endocrinol Metab Source Type: research